Obtained CRB approval for a multicenter specific clinical study regarding the effects of an unapproved medical device program for pediatric amblyopia training using VR.
New Approach to Pediatric Amblyopia Training, Collaboration with Medical Institutions for Clinical Research Launch
For the "medical device for pediatric amblyopia training using VR (not approved)" that our company is developing, we have obtained approval from the Certified Clinical Research Review Board (CRB) on August 26, 2025, to carry out specific clinical research under the Clinical Research Act.
We will collaborate with multiple medical institutions and begin the specific clinical research as soon as preparations are complete.
Background of the Research
Amblyopia is a condition where vision in one or both eyes does not develop sufficiently, with an incidence rate of about 1-5% in children. In Japan, there are approximately 210,000 amblyopia patients, and the social loss is estimated to be around 2.2 trillion yen.
Treatment for amblyopia generally involves wearing corrective glasses and, if that is insufficient, using occlusion therapy on the better-seeing eye, such as eye patches. However, occlusion therapy places a considerable psychological and physical burden on children as it involves covering the eye that sees well, often making it difficult to continue treatment. Furthermore, there is a "sensitive period" for the development of children's visual functions that lasts until around the age of 10, and missing this period can lead to insufficient treatment effects.
InnoJin's New Approach
In response to these challenges, our company is working on the development of an innovative amblyopia training medical device utilizing virtual reality (VR) technology. By providing an environment where children can wear VR goggles to engage in games such as kendama, table tennis, and tennis, we aim to naturally eliminate psychological burdens associated with treatment while having fun. Furthermore, we seek to improve treatment adherence and enhance treatment effects.
Table tennis game screen image
Tennis game screen image
Future Prospects
Currently, we are advancing specific clinical research and efforts towards practical application of the pediatric amblyopia training medical device (not approved) using VR in collaboration with multiple medical institutions. In the future, we aim to provide an amblyopia training program that can be implemented at home through medical institutions.
InnoJin Co., Ltd. is committed to realizing a society where
“all children can grow up without the handicap of visual impairment.”
We will continue to engage in research and development of innovative medical solutions going forward.
Press Release Article